{"id":37552,"date":"2014-09-08T13:53:34","date_gmt":"2014-09-08T13:53:34","guid":{"rendered":"http:\/\/www.ou.org\/life\/?p=37552"},"modified":"2014-09-08T14:41:27","modified_gmt":"2014-09-08T14:41:27","slug":"israel-answer-ebola","status":"publish","type":"post","link":"https:\/\/www.ou.org\/life\/israel\/israel-answer-ebola\/","title":{"rendered":"Does Israel Have the Answer to Ebola?"},"content":{"rendered":"<p>Protalix, an Israeli biopharmaceutical company located outside of the northern city of Carmiel, said Saturday that it has the resources to produce the experimental Ebola vaccine, ZMapp, which has recently run out.<\/p>\n<p>In an interview with Channel 2, Protalix\u2019s Dr. Yossi Shaaltiel, the executive vice president of research and development said: \u201cToday our production capacity exceeds our needs, and we would certainly be happy to have the company producing the Ebola drug have us produce the drug for them. We would know how to do it effectively, in large quantities, and in a relatively short period of time.\u201d<\/p>\n<p>Read more at <a href=\"http:\/\/www.timesofisrael.com\/israeli-company-says-it-can-produce-experimental-ebola-drug\/\">The Times of Israel<\/a> <\/p>\n<p>Related: <a href=\"http:\/\/www.ou.org\/news\/pfizer-prescription-medication-gaucher-disease-receives-ou-kosher-certification\/\">Pfizer Prescription Medication for Gaucher Disease Receives OU Kosher Certification<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Protalix, an Israeli biopharmaceutical company located outside of the northern city of Carmiel, said Saturday that it has the resources to produce the experimental Ebola vaccine, ZMapp, which has recently run out. In an interview with Channel 2, Protalix\u2019s Dr. Yossi Shaaltiel, the executive vice president of research and development said: \u201cToday our production capacity<\/p>\n","protected":false},"author":730,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1,96,11],"tags":[],"class_list":["post-37552","post","type-post","status-publish","format-standard","hentry","category-israel","category-news","category-technology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Does Israel Have the Answer to Ebola? - OU Life<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ou.org\/life\/israel\/israel-answer-ebola\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Does Israel Have the Answer to Ebola? - OU Life\" \/>\n<meta property=\"og:description\" content=\"Protalix, an Israeli biopharmaceutical company located outside of the northern city of Carmiel, said Saturday that it has the resources to produce the experimental Ebola vaccine, ZMapp, which has recently run out. In an interview with Channel 2, Protalix\u2019s Dr. Yossi Shaaltiel, the executive vice president of research and development said: \u201cToday our production capacity\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ou.org\/life\/israel\/israel-answer-ebola\/\" \/>\n<meta property=\"og:site_name\" content=\"OU Life\" \/>\n<meta property=\"article:published_time\" content=\"2014-09-08T13:53:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2014-09-08T14:41:27+00:00\" \/>\n<meta name=\"author\" content=\"OU Staff\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"OU Staff\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ou.org\/life\/israel\/israel-answer-ebola\/\",\"url\":\"https:\/\/www.ou.org\/life\/israel\/israel-answer-ebola\/\",\"name\":\"Does Israel Have the Answer to Ebola? - OU Life\",\"isPartOf\":{\"@id\":\"https:\/\/www.ou.org\/life\/#website\"},\"datePublished\":\"2014-09-08T13:53:34+00:00\",\"dateModified\":\"2014-09-08T14:41:27+00:00\",\"author\":{\"@id\":\"https:\/\/www.ou.org\/life\/#\/schema\/person\/9c39ad0f9b2550fe954412311bba3b65\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ou.org\/life\/israel\/israel-answer-ebola\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ou.org\/life\/#website\",\"url\":\"https:\/\/www.ou.org\/life\/\",\"name\":\"OU Life\",\"description\":\"Everyday Jewish Living\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ou.org\/life\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ou.org\/life\/#\/schema\/person\/9c39ad0f9b2550fe954412311bba3b65\",\"name\":\"OU Staff\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ou.org\/life\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/41f3b263e2651da41869efe41b7331cd4ac5453e1719e202d7f0c46360626601?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/41f3b263e2651da41869efe41b7331cd4ac5453e1719e202d7f0c46360626601?s=96&d=mm&r=g\",\"caption\":\"OU Staff\"},\"url\":\"https:\/\/www.ou.org\/life\/author\/oustaff-me\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Does Israel Have the Answer to Ebola? - OU Life","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ou.org\/life\/israel\/israel-answer-ebola\/","og_locale":"en_US","og_type":"article","og_title":"Does Israel Have the Answer to Ebola? - OU Life","og_description":"Protalix, an Israeli biopharmaceutical company located outside of the northern city of Carmiel, said Saturday that it has the resources to produce the experimental Ebola vaccine, ZMapp, which has recently run out. In an interview with Channel 2, Protalix\u2019s Dr. Yossi Shaaltiel, the executive vice president of research and development said: \u201cToday our production capacity","og_url":"https:\/\/www.ou.org\/life\/israel\/israel-answer-ebola\/","og_site_name":"OU Life","article_published_time":"2014-09-08T13:53:34+00:00","article_modified_time":"2014-09-08T14:41:27+00:00","author":"OU Staff","twitter_card":"summary_large_image","twitter_misc":{"Written by":"OU Staff","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ou.org\/life\/israel\/israel-answer-ebola\/","url":"https:\/\/www.ou.org\/life\/israel\/israel-answer-ebola\/","name":"Does Israel Have the Answer to Ebola? - OU Life","isPartOf":{"@id":"https:\/\/www.ou.org\/life\/#website"},"datePublished":"2014-09-08T13:53:34+00:00","dateModified":"2014-09-08T14:41:27+00:00","author":{"@id":"https:\/\/www.ou.org\/life\/#\/schema\/person\/9c39ad0f9b2550fe954412311bba3b65"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ou.org\/life\/israel\/israel-answer-ebola\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.ou.org\/life\/#website","url":"https:\/\/www.ou.org\/life\/","name":"OU Life","description":"Everyday Jewish Living","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ou.org\/life\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.ou.org\/life\/#\/schema\/person\/9c39ad0f9b2550fe954412311bba3b65","name":"OU Staff","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ou.org\/life\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/41f3b263e2651da41869efe41b7331cd4ac5453e1719e202d7f0c46360626601?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/41f3b263e2651da41869efe41b7331cd4ac5453e1719e202d7f0c46360626601?s=96&d=mm&r=g","caption":"OU Staff"},"url":"https:\/\/www.ou.org\/life\/author\/oustaff-me\/"}]}},"acf":[],"brizy_media":[],"_links":{"self":[{"href":"https:\/\/www.ou.org\/life\/wp-json\/wp\/v2\/posts\/37552","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ou.org\/life\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ou.org\/life\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ou.org\/life\/wp-json\/wp\/v2\/users\/730"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ou.org\/life\/wp-json\/wp\/v2\/comments?post=37552"}],"version-history":[{"count":2,"href":"https:\/\/www.ou.org\/life\/wp-json\/wp\/v2\/posts\/37552\/revisions"}],"predecessor-version":[{"id":37561,"href":"https:\/\/www.ou.org\/life\/wp-json\/wp\/v2\/posts\/37552\/revisions\/37561"}],"wp:attachment":[{"href":"https:\/\/www.ou.org\/life\/wp-json\/wp\/v2\/media?parent=37552"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ou.org\/life\/wp-json\/wp\/v2\/categories?post=37552"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ou.org\/life\/wp-json\/wp\/v2\/tags?post=37552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}